Please Wait
Applying Filters...
menu
    • menu
    Default Key Product, Service and Excipients
    News
    Xellia starts commercial production and distribution of premix bag products

    29 Nov 2023

    // BUSINESSWIRE

    Xellia Pharmaceuticals Cleveland, Ohio Manufacturing site is now operational.

    17 Aug 2021

    // BUSINESSWIRE

    Xellia Pharms Aps's Generic Micafungin Sodium Receives Approval In US

    02 Jun 2021

    // FDA

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    CPhI Milan

    Booth #18A31

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/prostaglandin-market-to-cross-us-1-27-bn-by-2035-liquidia-s-yutrepia-okayed-for-pulmonary-hypertension
    Menu

    Xellia Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Amphotericin B

    02 1Bacitracin

    03 1Bacitracin Zinc

    04 1Colistimethate Sodium

    05 1Dalbavancin

    06 1Daptomycin

    07 1Fidaxomicin

    08 1Gramicidin

    09 1Polymyxin B Sulfate

    10 1Tobramycin Sulfate

    11 1Tyrothricin

    12 1Vancomycin Hydrochloride

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphotericin B

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    01

    Amphotericin B

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bacitracin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    02

    Bacitracin

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bacitracin Zinc

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    03

    Bacitracin Zinc

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Colistimethate Sodium

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    04

    Colistimethate Sodium

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Dalbavancin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    05

    Dalbavancin

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daptomycin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    06

    Daptomycin

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Fidaxomicin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    07

    Fidaxomicin

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Gramicidin

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    08

    Gramicidin

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Polymyxin B Sulfate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    09

    Polymyxin B Sulfate

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Tobramycin Sulfate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitmen...
    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    10

    Tobramycin Sulfate

    Denmark
    arrow
    CPhI Milan
    Booth #18A31
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothXellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
    Contact Supplier Contact Supplier
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Xellia Pharmaceuticals

    Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of essential anti-infective APIs, we combine EU-based production with a proven record of uninterrupted supply. Backed by deep expertise and long-term commitment, we continuously invest in quality, compliance, and manufacturing excellence to ensure reliable access to critical medicines worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Xellia is a global leader in fermentation-based anti-infectives, supplying APIs and finished dosage forms for severe and life-threatening infections. As one of the last Western manufacturers of ...

    Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Xellia Pharmaceuticals and get a quotation

    Xellia Pharmaceuticals is a supplier offers 24 products (APIs, Excipients or Intermediates).

    Find Amphotericin B bulk with DMF, CEP, JDMF offered by Xellia Pharmaceuticals

    Find Bacitracin Zinc bulk with DMF, CEP, JDMF offered by Xellia Pharmaceuticals

    Find Colistimethate Sodium bulk with DMF, CEP, JDMF offered by Xellia Pharmaceuticals

    Find Polymyxin B Sulfate bulk with DMF, CEP, JDMF offered by Xellia Pharmaceuticals

    Find Vancomycin Hydrochloride bulk with DMF, CEP, JDMF offered by Xellia Pharmaceuticals

    Find Gramicidin bulk with CEP, JDMF offered by Xellia Pharmaceuticals

    Find Bacitracin Zinc bulk with DMF, CEP offered by Xellia Pharmaceuticals

    Find Colistimethate Sodium bulk with CEP, JDMF offered by Xellia Pharmaceuticals

    Find Colistin Sulfate bulk with DMF, CEP offered by Xellia Pharmaceuticals

    Find Vancomycin Hydrochloride bulk with DMF, CEP offered by Xellia Pharmaceuticals

    Find Bacitracin Zinc bulk with CEP offered by Xellia Pharmaceuticals

    Find Amphotericin B bulk with JDMF offered by Xellia Pharmaceuticals

    Find Bacitracin Zinc bulk with DMF offered by Xellia Pharmaceuticals

    Find Dalbavancin bulk with DMF offered by Xellia Pharmaceuticals

    Find Daptomycin bulk with DMF offered by Xellia Pharmaceuticals

    Find Gramicidin bulk with DMF offered by Xellia Pharmaceuticals

    Find Tobramycin bulk with DMF offered by Xellia Pharmaceuticals

    Find Tyrothricin bulk with CEP offered by Xellia Pharmaceuticals

    Find Caspofungin bulk offered by Xellia Pharmaceuticals

    Find Mupirocin bulk offered by Xellia Pharmaceuticals

    Find Tobramycin Sulfate bulk offered by Xellia Pharmaceuticals

    Find Colistimethate Sodium bulk offered by Xellia Pharmaceuticals

    Find Fidaxomicin bulk offered by Xellia Pharmaceuticals

    Find Polymyxin B Sulfate bulk offered by Xellia Pharmaceuticals

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.